[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345336-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345336-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","risk-insights-for-clinical-medication-a-mendelian-randomization-study-of-23-drugs-and-lung-cancer","Risk insights for clinical medication - a Mendelian randomization study of 23 drugs and lung cancer","","Clinical medications for common diseases have attracted attention regarding potential effects on cancer risk, yet causal links to lung cancer remain uncertain. Genome-wide association study datasets for 23 drug classes and lung cancer were extracted from public resources, and Mendelian randomization was applied to estimate causal effects. Sensitivity analyses assessed robustness. Salicylic acid and derivatives reduced lung cancer risk, whereas opioids increased risk. After outlier correction, some suggestive associations strengthened or weakened, while overall findings remained stable.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/risk-insights-for-clinical-medication-a-mendelian-randomization-study-of-23-drugs-and-lung-cancer/345336/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/risk-insights-for-clinical-medication-a-mendelian-randomization-study-of-23-drugs-and-lung-cancer/345336.png","ImageObject",300,407,{"name":42,"@type":43},"Oliver","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What causal relationship does the study evaluate for lung cancer?","Question",{"text":63,"@type":64},"It evaluates whether multiple commonly used clinical drugs have causal effects on lung cancer risk using Mendelian randomization with genetic variants as instruments.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which drug class showed a protective effect and which increased risk?",{"text":68,"@type":64},"Salicylic acid and derivatives were associated with reduced lung cancer risk, while opioids were associated with increased lung cancer risk, based on the reported odds ratios and significance levels.",{"name":70,"@type":61,"acceptedAnswer":71},"How were the results tested for stability and reliability?",{"text":72,"@type":64},"The study conducted sensitivity analyses and applied outlier removal/correction to examine whether key associations remained robust and how suggestive signals changed.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345336,1790693535,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Naunyn-Schmiedeberg's Archives of Pharmacology (2026) 399:9871–9879 [https://doi.org/10.1007/s00210-025-04967-2](https://doi.org/10.1007/s00210-025-04967-2)  \nRisk insights for clinical medication: a Mendelian randomization study of 23 drugs and lung cancer  \nHuachuan Wang1 · Bo Zhou2 · Baowei Ma2 · Tao Zhang2 · Ranran Kong1  \nReceived: 9 September 2025 / Accepted: 31 December 2025 / Published online: 27 January 2026 © The Author(s) 2026  \nAbstract  \nThe effect of clinical medications for common diseases on cancer risk has attracted extensive attention. However, whether they have a causal relationship with lung cancer remains unclear. Genome-wide association study datasets on 23 drugs and lung cancer were extracted from publicly available databases. Mendelian randomization methods were utilized to assess the causal effects of the drugs on the risk of lung cancer. Sensitivity analyses were also conducted to evaluate the stability and reliability. Our results found that salicylic acid and derivatives (OR = 0.779; 95% CI, 0.676–0. 898; P = 5 × 10−4, P-adjusted = 0.0125) significantly reduced lung cancer risk, while opioids (OR = 1. 16; 95% CI, 1.065–1.263; P = 6 × 10−4, P-adjusted = 0.0148) significantly increased lung cancer risk. These findings remained robust after removing outliers. Suggestive evidence for a protective effect was also found for antithrombotic agents, antihypertensives, β-blockers, thyroid preparations, and anilines (all 0.0022 \u003C P \u003C 0.05) . Notably, after outlier correction, the suggestive association for antithrombotic agents became statistically significant, while that for β-blockers disappeared, and the other suggestive associations persisted. Sensitivity analyses further confirmed the robustness of these findings. This study identified several clinical drugs that were causally associated with lung cancer, involving cardiovascular and endocrine system medications, anti-inflammatory/ antipyretic analgesics, and centrally acting analgesics. It provides a theoretical reference for clinical medication guidance and understanding medication risks.  \nKeywords Mendelian randomization · Drugs · Lung cancer · Causality  \nIntroduction  \nLung cancer is one of the malignant tumors that poses a serious threat to human health worldwide (Bray et al. 2024 ; Filho et al. 2025) . In recent years, the incidence of lung cancer has increased significantly, becoming a leading cause of cancer-related death (Filho et al. 2025 ; Kong et al. 2023) . Although smoking and air pollution are traditional pathogenic factors, some studies have found a significantly higher risk of lung cancer in patients with chronic diseases (Hatlenet al. 2014 ; Malhotra et al. 2016 ; Patel and Priefer 2022), suggesting the importance of non-traditional risk factors.  \n* Ranran Kong [r.kong@xjtu.edu.cn](r.kong@xjtu.edu.cn)  \n1 Department of Thoracic Surgery, the Second Affiliated Hospital of Xi’an Jiaotong University, No. 157, Xiwu Road, Xi’an 710004, Shaanxi, China  \n2 Department of Thoracic Surgery, The First People’s Hospital of Dazhou, Dazhou 635000, China  \nAgainst this backdrop, a critical yet unresolved question arises: Could long-term clinical medications used for these chronic diseases be a potential driver of altered lung cancer risk?  \nThe practical significance of this issue has become increasingly prominent with the growing prevalence of multimorbidity. For individuals living with multiple chronic conditions, long-term exposure to commonly used clinical drugs (such as antihypertensives and hypoglycemic drugs) has become a common phenomenon (van Dorst et al. 2021) . Notably, many drugs unintentionally alter the risk of other diseases when treating the primary disease (Lebrun and Rocher 2018 ; Sauter and Agurs-Collins 2024) . This trend is increasingly relevant in the risk of tumor occurrence, including lung cancer. For example, observational studies showed that antihypertensives and hypoglycemic drugs were associated with a lower risk of lung c","cbCaivDA8QHk34Hj","https://ap.wps.com/l/cbCaivDA8QHk34Hj","pdf",1240752,"English","# Abstract\n# Introduction\n# Materials and methods\n## Study design\n## Data source","[{\"question\":\"What causal relationship does the study evaluate for lung cancer?\",\"answer\":\"It evaluates whether multiple commonly used clinical drugs have causal effects on lung cancer risk using Mendelian randomization with genetic variants as instruments.\"},{\"question\":\"Which drug class showed a protective effect and which increased risk?\",\"answer\":\"Salicylic acid and derivatives were associated with reduced lung cancer risk, while opioids were associated with increased lung cancer risk, based on the reported odds ratios and significance levels.\"},{\"question\":\"How were the results tested for stability and reliability?\",\"answer\":\"The study conducted sensitivity analyses and applied outlier removal/correction to examine whether key associations remained robust and how suggestive signals changed.\"}]","Risk insights for clinical medication - a Mendelian randomization study of 23 drugs and lung cancer | PDF",1790057323,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9fbf17e2f9f7d20500e7526abf791c62.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12e908feea18cc01565a7d262affecda.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d7ffd7584d7de8eef1a89170dc26f5f.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/967244995e4b348e02c7e8eac6021479.webp",980,1301]